PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 61,730 shares, a growth of 208.7% from the July 15th total of 20,000 shares. Based on an average trading volume of 228,548 shares, the days-to-cover ratio is presently 0.3 days.

PharmaTher Trading Up 13.6%

OTCMKTS PHRRF opened at $0.04 on Friday. The business’s fifty day moving average is $0.04 and its 200 day moving average is $0.05. PharmaTher has a fifty-two week low of $0.03 and a fifty-two week high of $0.35.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.